Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosome

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Nature Genetics

• Publication date

  1992-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/NG1092-128PMID 1303261
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Closing in on a breast cancer gene on chromosome 17q.

  1992cited by this paper
• The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer.

  1992cited by this paper
• Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms.

  1992cited by this paper
• Familial breast-ovarian cancer locus on chromosome 17q12-q23.

  1991cited by this paper
• Dinucleotide repeat polymorphism at the D15S87 locus.

  1990cited by this paper
• Allele losses on chromosome 17 in human epithelial ovarian carcinoma.

  1990cited by this paper
• Linkage of early-onset familial breast cancer to chromosome 17q21.

  1990cited by this paper
• Allele loss from chromosome 17 in ovarian cancer.

  1990cited by this paper
• Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

  1990cited by this paper
• Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development

  1989cited by this paper
• Evidence for a novel gene associated with low tumor metastatic potential.

  1988cited by this paper
• Cancer. Gene losses in human tumours.

  1988cited by this paper
• Gene losses in human tumours

  1988cited by this paper

• Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma

  2025cites this paper
• Participants in Transcription–Replication Conflict and Their Role in Formation and Resolution of R-Loops

  2025cites this paper
• Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma

  2025cites this paper
• Aromatics from fossil fuels and breast cancer.

  2025cites this paper
• Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers.

  2025cites this paper
• CLINICOPATHOLOGICAL STUDY OF BREAST CANCER AND IMMUNOHISTOCHEMICAL EXPRESSION OF BRCA 1 AND BRCA2 – A PROSPECTIVE STUDY

  2024cites this paper
• The deubiquitinating enzyme USP4 regulates BRCA1 stability and function

  2024cites this paper
• BRCA Status Dictates Wnt Responsiveness in Epithelial Ovarian Cancer

  2024cites this paper
• BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma.

  2023cites this paper
• Functional annotation of variants of the BRCA2 gene via locally haploid human pluripotent stem cells

  2023cites this paper
• BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma

  2023cites this paper
• BRCA1/2 haploinsufficiency: exploring the impact of losing one allele.

  2023cites this paper
• Comparison of Survival Outcomes According to BRCA1/2 Variant Type in High-grade Serous Ovarian Cancer

  2022cites this paper
• CRL4-DCAF8L1 Regulates BRCA1 and BARD1 Protein Stability

  2022cites this paper
• Practice guidelines for BRCA1/2 tumour testing in ovarian cancer

  2022cites this paper
• Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy

  2022cites this paper
• Loss of Heterozygosity of BRCA1/2 as a Predictive Marker for Talazoparib Response

  2022cites this paper
• A BRCA1 Splice Site Variant Responsible for Familial Ovarian Cancer in a Han-Chinese Family

  2022cites this paper
• Advanced Approaches to Breast Cancer Classification and Diagnosis

  2021cites this paper
• Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese Population

  2021cites this paper
• Tsc2 mutation induces renal tubular cell nonautonomous disease

  2021cites this paper
• Untangling the crosstalk between BRCA1 and R-loops during DNA repair

  2021cites this paper
• Hereditary Gynecological Malignancy and Molecular Features

  2021cites this paper
• Fertility preservation in BRCA mutation carriers—efficacy and safety issues: a review

  2020cites this paper
• BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan

  2020cites this paper
• Detecting Large Germline Rearrangements of BRCA1 by Next Generation Tumor Sequencing

  2020cites this paper
• Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer

  2019cites this paper
• The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability

  2019cites this paper
• Cancer Epigenetics for Precision Medicine

  2018cites this paper
• INHERITED GENETIC SUSCEPTIBILITY TO BREAST CANCER IN PAKISTAN

  2018cites this paper
• Frequency of BRCA1 (185delAG and 5382insC) and BRCA2 (6174delT) mutations in Egyptian women with breast cancer compared to healthy controls

  2018cites this paper
• Interplay Between Genetic and Epigenetic Changes in Breast Cancer Subtypes.

  2018cites this paper
• Genetics of gynaecological cancers.

  2017cites this paper
• BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers

  2017cites this paper
• Identification of KIT as a Suppressor of BRAFV600E-Mutant Melanoma

  2017cites this paper
• CTLA-4 Genetic Variants (rs11571317 and rs3087243): Role in Susceptibility and Progression of Breast Cancer

  2017cites this paper
• Identification and analysis of concurrent multiple nucleotide substitutions

  2016cites this paper
• Accelerated geroncogenesis in hereditary breast-ovarian cancer syndrome

  2016cites this paper
• The biological effects and clinical implications of BRCA mutations: where do we go from here?

  2016cites this paper
• pre-mRNAs containing multiple intervening sequences?

  2016cites this paper
• Breast cancer predisposition gene brca1, pathogenic c61g mutation in mice: synthetic viability in DNA repair and tumour development

  2016cites this paper
• Síndrome de cáncer de mama y ovario hereditario: Estudio in vitro de variantes BRCA1 y BRCA2 de significado biológico desconocido y búsqueda de nuevos genes responsables de este síndrome

  2016cites this paper
• NEK8 regulates DNA damage-induced RAD51 foci formation and replication fork protection

  2016cites this paper
• Differentiating mammary carcinoma from ovarian and endometrial carcinoma using GATA3, MAM, and PAX8 expression: validations and limitations

  2016cites this paper
• Cardiovascular risk of BRCA1/2 mutation carriers: A review.

  2016cites this paper
• Exploiting synthetic lethality in ovarian cancer

  2016cites this paper
• Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

  2016cites this paper
• Expression of BRCA1 and BRCA2 proteins and their correlation with clinical staging in breast cancer.

  2015cites this paper
• ROLE OF BRCA1 AND BRCA2 GENES IN CELLULAR METABOLISM AND BREAST CANCER

  2015cites this paper
• Analysis of BRCA 1 and BRCA 2 Mutations in Eastern Egyptian Breast Cancer Patients

  2015cites this paper
• Copy Number Changes in Carcinomas: Applications

  2015cites this paper
• The Role of BRCT-Containing Proteins BRCA1 and PAXIP1 in Cancer

  2015cites this paper
• Probing Structure-Function Relationships in Missense Variants in the Carboxy-Terminal Region of BRCA1

  2014cites this paper
• Identification, Isolation and Amplification of BRCA1 Gene Involved on Breast Cancer.

  2014cites this paper
• Molecular factors influencing epithelial-mesenchymal transition in breast cancer

  2014cites this paper
• BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different

  2014cites this paper
• The aetiology of XX true hermaphroditism in the southern African black population

  2014cites this paper
• Novel Approaches to Studying BRCA Variants of Unknown Clinical Significance

  2014cites this paper
• BRCA1 Haploinsufficiency Leads to Altered Expression of Genes Involved in Cellular Proliferation and Development

  2014cites this paper
• New insights into the genetic basis of colorectal cancer

  2014cites this paper
• Identification and functional analysis of a novel renal cell carcinoma (RCC) susceptibility gene from an RCC associated constitutional chromosomal translocation.

  2013cites this paper
• Selected rapporteur summaries from the XX world congress of psychiatric genetics, Hamburg, Germany, october 14–18, 2012

  2013cites this paper
• Selection of a Non-Phosphorylated Peptide Inhibitor of BRCA1’s (BRCT)2 Domain

  2013cites this paper
• Epigenetic modifications in breast cancer and their role in personalized medicine.

  2013cites this paper
• Targeting Signaling Pathways in Epithelial Ovarian Cancer

  2013cites this paper
• Chromosome instability and carcinogenesis: Insights from murine models of human pancreatic cancer associated with BRCA2 inactivation

  2013cites this paper
• Validation of a Gene-Expression Based Assay for BRCA1 Function

  2013cites this paper
• Genetic predisposition for cancer : genes and genetic counseling

  2012cites this paper
• Role of BRCA1 in controlling mitotic arrest in ovarian cystadenoma cells

  2012cites this paper
• Germline Copy Number Variation and Cancer Risk

  2012cites this paper
• BRCA1 as a tumor suppressor linked to the regulation of epigenetic states: keeping oncomiRs under control

  2012cites this paper
• Oncogenomic pattern detection in cancer copy number alteration data for pathway description and dieases classification

  2012cites this paper
• Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells

  2011cites this paper
• Studying Therapy Response and Resistance in Mouse Models for BRCA1-Deficient Breast Cancer

  2011cites this paper
• Haplo‐insufficiency: a driving force in cancer

  2011cites this paper
• Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis.

  2011cites this paper
• UDP-glucuronosyltransferase 2B7 glucuronidation of the active tamoxifen metabolites

  2011cites this paper
• Old and new concepts in histopathological characterization of familial breast cancer.

  2011cites this paper
• The genetics and molecular biology of gynaecological cancer

  2011cites this paper
• The Role of BRCA1 Domains and Motifs in Tumor Suppression

  2011cites this paper
• A continuum model for tumour suppression

  2011cites this paper
• The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population

  2011cites this paper
• BP1, an Isoform of DLX4 Homeoprotein, Negatively Regulates BRCA1 in Sporadic Breast Cancer

  2010cites this paper
• Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2

  2010cites this paper
• Fine tuning chemotherapy to match BRCA1 status.

  2010cites this paper
• A critical re-appraisal of BRCA1 methylation studies in ovarian cancer.

  2010cites this paper
• 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

  2010cites this paper
• Targeting homologous recombination repair defects in cancer.

  2010cites this paper
• Characterization of the mouse and human breast cancer genome

  2010cites this paper
• Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers

  2010cites this paper
• Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation

  2010cites this paper
• Sind wir polyploid

  2010cites this paper
• Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families

  2010cites this paper
• Molecular cloning and functional studies of tenascin-C isoforms containing the fibronectin-type III repeat additional domain 1 (AD1)

  2009cites this paper
• A High-Throughput Pharmaceutical Screen Identifies Compounds with Specific Toxicity against BRCA2-Deficient Tumors

  2009cites this paper
• PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.

  2009cites this paper
• Genetic epidemiology of breast cancer in CYPRUS: A case -control study of DNA repair genes

  2009cites this paper
• [Implications of genetic risk factors in breast cancer: culprit genes and associated malignancies].

  2009cites this paper
• Fanconi anemia pathway defects in sporadic cancer

  2009cites this paper
• Altered proliferation and differentiation properties of primary mammary epithelial cells from BRCA1 mutation carriers.

  2009cites this paper